Scancell Share Discussion Threads

[2tyke] 12/7/2023 15:16

Panama,
You can"t really blame the happy clappers as such. They just don't understand stock movement..like inanaco doesn't.
It"s probably borne from watching the occasional biotech soar on good news...as it will in a 3rd wave.
Not in a second wave however;
Just think about the times a small company has struck gold or oil, only for the stock price to fall. It depends entirely on where the stock is in its pattern.
Yes..I am an education aren't I...lol.
Anyway...with SCLP now reaching the 10p area or 61.8 % retrace, it's a good time to start buying.
It doesn't mean it can"t fall further ..but it's very low risk to phase in now.

[panama7] 12/7/2023 15:05

Knowlesi, you are far too much of a realist for the happy clappers on here. They have been living in denial now for 10 years and refuse to believe what they are seeing with their own eyes.

[knowlesi] 12/7/2023 14:59

Inanaco - I don't think it has failed. But one shot at goal has gone imo - modi1 as a montherapy isn't going to happen (in my opinion and based on LD comments). Shot at goal missed hence valuation lowered. As per my post - and pretty much all my posts - still think this has long term value. We don't disagree there. I would seriously challenge the 8 quid mantra (not a chance) but 75p-£1. Yep - I could possibly see 1.50 but modi1 results are a huge blow and but a real ceiling on valuation going forward. All my opinion. I also seriously doubt a CI will partner a combination drug that needs 4 injections - that is ridiculous. Remember - we turned down CI combo trial in 2015 - 8 years later here we are. Not great. The share price the last 2 days tells you that. Down 20% is just the start. As per my post yesterday single digits is coming and possibly testing new lows. Risk up, timelines increased, more potential jam tomorrow - market says no thanks.

[markingtime] 12/7/2023 14:59

I shall be interested in the next RNS.RG had a load of options too.....they had 6.73mn between them, all expiring at the end of July.I'd guess that both have exercised their options today and that 6.73mn new shares have been issued, of which a large chunk has been sold (mostly by RG, as he is no longer with the company). It will be interesting to see how many newly-issued shares LD has retained - and whether the shares bought in the market prompt any holding RNSs. Eg Vulpes could have bought a few - they have the capacity and have been cleansed by Monday's news release.We should find out tomorrow or after the close today.

[inanaco] 12/7/2023 14:49

BBC will be after you soon ....

[2tyke] 12/7/2023 14:46

I do a commentary on Bitcoin on another bb inane...in real time.
It's usually correct....you won't be surprised to hear.

[inanaco] 12/7/2023 14:44

smart boy ...a crypto scientist of patterns

what next i wonder .....

[2tyke] 12/7/2023 14:42

It's probably true inane....read em and weep !
But then...I am a very experienced elliottician.
Something else you may be interested to hear....I used to be a pharmaceutical research scientist in a past life. So I understand all your science posts...as irrelevant as they are to the stock price.
It turns out that research scientists have the skills necessary to 'see wave patterns'
The market is a place of irony...and...

[inanaco] 12/7/2023 14:41

declare your trades ............ as you make them we can watch them go through the exchange

[inanaco] 12/7/2023 14:38

2 tike ...... in your dreams

[2tyke] 12/7/2023 14:35

Inane,
My top positions are all crypto related. I sold Bitcoin at 60 odd thousand and followed wave 2 down to 15k to buy in again. You held SCLP throughout wave 2...you fool.
Almost all my current crypto trades have 5 bagged over the past 6 weeks.
My level of involvement in crypto alone is probably larger than your total net wealth.
Yes...I will mop up all the SCLP shares the bulls are throwing away...don't worry.

[inanaco] 12/7/2023 14:35

and please note the share moved because of RNS .......... not short or long term patterns

[inanaco] 12/7/2023 14:29

2 tike rather than telling us how great you are .. put £20,000 in !

money talks louder than your "patterns"

[2tyke] 12/7/2023 14:19

No moonparty...no.
Markets are NOT fickle.
Neither is it the punishing of cash burning companies Dominic.
ALL stocks move in exactly the same patterns. Just because you can't see the patterns doesn't mean they aren't there.
It's a knowledge thing.
If you haven't got it you are doomed to make the same mistakes time after time...like the masses.

[tosh123] 12/7/2023 14:05

Hi Ivy,
I take everything the idiot says with a pinch of salt.
The reality is that his " car park " is probably his own driveway.

The guy is delusional.

[panama7] 12/7/2023 13:47

Ivy, what idiot would buy a car park in this day and age when councils across the country are doing everything in their power to make driving more and more difficult. I wonder if he has invested in charging points for the EV's that kids as young as 4 are mining cobalt for.

[panama7] 12/7/2023 13:40

Plasbryn, are you talking about the fall in share price over the last 10 years from 60p all the way to 10p. Might have something to do with Scancell failing to achieve anything more than a 5m down payment. In that time innumerable companies have sold preclinical assets for 100's of millions and in several cases for a billion or more.

[dominiccummings] 12/7/2023 13:33

Calm down folks. It is high interest rates and the punishing of a sector that mostly burns cash. This company is well funded, mainly by large investors that understand markets and risk. Because of the excellence of it's science this company will survive and then thrive.

[ivyspivey] 12/7/2023 13:28

Hi Tosh,
Good to hear from you on here.
You may want to keep an eye out in local paper for car parks for sale. I hear of a distressed seller who may wish to offload one to cover up for his losses here today.
ATB

[marcusl2] 12/7/2023 12:43

SCIB1 – Phase 1/2 reduced recurrence and turned cancer into a chronic disease
88% of patients remained disease-free for 5+ years

With the addition of doublet CPI we have improved that. iScib+ will further improve the treatment.

Modi-1 is working. We are early days in the Modi-1 HIGH DOSE plus CPI
Modi-2

SC129
• Pancreatic cancer (deal done with Genmab up to $624m and single digit
royalties) We retain rights to license to a Car T company.

SC134
• Small cell lung cancer

SC2811
• Any solid tumour, iSC2811 enhances T cell engraftment and prevents exhaustion
Potential for improving CAR-T approaches

SC88
• Colorectal cancer

SC27 • Lewisy
• Ovarian cancer

Avidimab is being proven, could be huge.

Now a 5th company is assessing an antibody.

Data pack is ready for deals with the Glymabs as Car Ts.

Updates on SCIB1 and Modi-1 will be presented at the AACR-CIMT meeting in Milan in September 2023.

[marcusl2] 12/7/2023 12:30

Well I have full confidence in the science and company.

Picked up a few more there.

Market cap 89.56M

[canaletto] 12/7/2023 12:27

The answer is....POS

[2tyke] 12/7/2023 12:07

Plasybryn,
It's lemming like yes...human behavioural science. it's patterned. They do the same things at similar times.
Investors think somebody 'must' know more than they do ..so they follow the leader.
Panic. The herding effect.